Michael Singer, M.D., Ph.D.
Chief Scientific Officer, Cartesian Therapeutics
Image
| Michael Singer is a serial entrepreneur, investor, and ophthalmologist. He has co-founded several life sciences companies, including HealthHonors (sold to Healthways in 2009) and Topokine (sold to Allergan in 2016). Most recently he co-founded Cartesian Therapeutics (NASDAQ: RNAC), a clinical-stage company developing a new generation of RNA-modified cell therapies. Mike is also a registered patent agent. He is named as inventor on over 100 issued patents and has written over 25 peer-reviewed scientific papers. He serves as an independent director at several life sciences companies. Mike completed his B.S. in Biology, Ph.D. in Neuroscience, and M.D. at Yale, followed by internship and residency at Harvard. |